isoquinoline-1,3,4-trione: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ID Source | ID |
---|---|
PubMed CID | 10640 |
CHEMBL ID | 206435 |
SCHEMBL ID | 1122624 |
MeSH ID | M0505177 |
Synonym |
---|
unii-bm68cv5x6q |
5-21-11-00575 (beilstein handbook reference) |
bm68cv5x6q , |
LS-13574 |
nsc 407248 |
1,3,4-(2h)isoquinolinetrione |
phthalonimide |
1,3,4(2h)-isoquinolinetrione |
brn 0383773 |
isoquinoline-1,3,4(2h)-trione |
RXA , |
nsc-407248 |
nsc407248 |
1,4(2h)-isoquinolinetrione |
521-73-3 |
isoquinoline-1,3,4-trione 1 |
1,2,3,4-tetrahydroisoquinoline-1,3,4-trione |
bdbm10247 |
isoquinoline-1,3,4-trione |
CHEMBL206435 |
AKOS006276226 |
3DEH |
SCHEMBL1122624 |
DTXSID40200103 |
Q27465167 |
FT-0753531 |
mfcd01717158 |
D81951 |
CS-0149741 |
Protein | Taxonomy | Measurement | Average | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
Chain C, Caspase-3 | Homo sapiens (human) | IC50 (µMol) | 0.1490 | 0.1490 | 0.1490 | 0.1490 | AID977608 |
Chain C, Caspase-3 | Homo sapiens (human) | IC50 (µMol) | 0.1490 | 0.1490 | 0.1490 | 0.1490 | AID977608 |
Chain C, Caspase-3 | Homo sapiens (human) | IC50 (µMol) | 0.1490 | 0.1490 | 0.1490 | 0.1490 | AID977608 |
Chain A, Caspase-3 | Homo sapiens (human) | IC50 (µMol) | 0.1490 | 0.1490 | 0.1490 | 0.1490 | AID977608 |
Prothrombin | Homo sapiens (human) | IC50 (µMol) | 5.0000 | 0.0000 | 0.7107 | 10.0000 | AID261396 |
Papain | Carica papaya (papaya) | IC50 (µMol) | 5.0000 | 0.0020 | 1.5045 | 10.0000 | AID261394 |
Calpain small subunit 1 | Homo sapiens (human) | IC50 (µMol) | 5.0000 | 7.0000 | 7.0000 | 7.0000 | AID261392 |
Calpain-1 catalytic subunit | Homo sapiens (human) | IC50 (µMol) | 5.0000 | 0.0002 | 1.0592 | 10.0000 | AID261392 |
Trypsin-1 | Homo sapiens (human) | IC50 (µMol) | 5.0000 | 0.0035 | 1.5321 | 10.0000 | AID261395 |
Trypsin-2 | Homo sapiens (human) | IC50 (µMol) | 5.0000 | 0.0035 | 1.5846 | 4.4000 | AID261395 |
Trypsin-3 | Homo sapiens (human) | IC50 (µMol) | 5.0000 | 0.0035 | 1.5846 | 4.4000 | AID261395 |
Caspase-3 | Homo sapiens (human) | IC50 (µMol) | 0.7663 | 0.0002 | 1.1979 | 8.8000 | AID1796413; AID261391 |
Caspase-2 | Homo sapiens (human) | IC50 (µMol) | 0.9965 | 0.0210 | 1.5556 | 5.0000 | AID1796413; AID261397 |
Caspase-7 | Homo sapiens (human) | IC50 (µMol) | 0.8058 | 0.0022 | 0.5477 | 5.0000 | AID1796413; AID261399 |
Caspase-6 | Homo sapiens (human) | IC50 (µMol) | 0.8205 | 0.0022 | 0.8652 | 5.0000 | AID1796413; AID261398 |
Caspase-8 | Homo sapiens (human) | IC50 (µMol) | 1.0598 | 0.0022 | 0.6845 | 5.0000 | AID1796413; AID261400 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.33) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |